Kiểm soát huyết áp trong perioperative: Khi nào nó sẽ ảnh hưởng xấu đến kết quả perioperative?

Aksnes TA, Kjeldsen SE, Rostrup M, et al.: Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population. Hypertension 2007, 50:467–473. Dahlof B, Sever PS, Poulter NR, et al.: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required in the Anglo-Scandinavian Outcome Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005, 366:895–906. Williams B, Lacy PS, Thom SM, et al.: Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006, 113:1213–1225. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al.: A calcium antagonist vs. a non calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil SR-Trandolapril Study (INVEST). Psychosom Med 2005, 67:398–406. Coriat P, Richer C, Douraki T, et al.: Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994, 81:299–307. Brabant SM, Bertrand M, Eyraud D, et al.: The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999, 89:1388–1392. Bertrand M, Godel G, Meersschaert K, et al.: Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001, 92:26–30. Pigott DW, Nagle C, Allman K, et al.: Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth 1999, 83:715–720. Wallace AW, Galindez D, Salahieh A, et al.: Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 2004, 101:284–293. Wijeysundera DN, Naik JS, Beattie WS: Alpha-2 adrenergic agonis to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003, 114:742–752. Biccard BM, Goga S, de Beurs J: Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of randomised controlled trials. Anaesthesia 2008, 63:4–14. Sear JW, Jewkes C, Tellez J-C, Foex P: Does the choice of antihypertensive therapy influence haemodynamic response to induction, laryngoscopy and intubation. Br J Anaesth 1994, 73:303–308. Stone JG, Foex P, Sear JW, et al.: Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988, 68:495–500. Kadoi Y, Saito S, Takahashi K: The comparative effects of sevoflurane vs isoflurane on cerebrovascular carbon dioxide reactivity in patients with hypertension. Acta Anaesthesiol Scand 2007, 51:1382–1387. Wallace A, Layug B, Tateo I, et al.: Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 1998, 88:7–17. Mangano DT, Layug EL, Wallace A, Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. New Engl J Med 1996, 335:1713–1720. Poldermans D, Boersma E, Bax JJ, et al.: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. New Engl J Med 1999, 341:1789–1794. Fleisher LA, Beckman JA, Brown KA, et al.: AAC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007, 116:1971–1996. POISE study group, Devereaux PJ, Yang H, et al.: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008, 371:1839–1847. Yang H, Raymer K, Butler R, et al.: The effects of perioperative beta-blockade: results of the metoprolol after vascular surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006, 152:983–990. Brady AR, Gibbs JS, Greenhalgh RM, et al.: POBBLE trial investigators: Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005, 41:602–609. Sprague HB: The heart in surgery. An analysis of the results of surgery on cardiac patients during the past ten years at the Massachusetts General Hospital. Surg Gynecol Obst 1929, 49:54–58. Prys-Roberts C, Meloche R, Foex P: Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients. Br J Anaesth 1971, 43:122–137. Prys-Roberts C, Greene LT, Meloche R, Foex P: Studies of anaesthesia in relation to hypertension. II. Haemodynamic consequences of induction and endotracheal intubation. Br J Anaesth 1971, 43:531–547. Prys-Roberts C, Foex P, Biro GP, Roberts JG: Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth 1973, 45:671–681. Goldman L, Caldera DL: Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 1979, 50:285–292. Forrest JB, Rehder K, Cahalan MK, Goldsmith CH: Multicenter Study of General Anesthesia. III: Predictors of severe perioperative adverse outcomes. Anesthesiology 1992, 76:3–15. Davenport DL, Ferraris VA, Hosokawa P, et al.: Multivariable predictors of postoperative cardiac adverse events after general and vascular surgery: results from the Patient Safety in Surgery study. J Am Coll Surg 2007, 204:1199–1210. Muir AD, Reeder MK, Foex P, et al.: Preoperative silent myocardial ischaemia: incidence and predictors in a general surgical population. Br J Anaesth 1991, 67:373–377. Allman KG, Muir A, Howell SJ, et al.: Resistant hypertension and pre-operative silent myocardial ischaemia in surgical patients. Br J Anaesth 1994, 73:574–578. Browner WS, Li J, Mangano DT; Study of Perioperative Ischemia Research Group: In-hospital and long-term mortality in male veterans following non-cardiac surgery. JAMA 1992, 268:228–232. Mangano DT, Browner WS, Hollenberg M, et al.; Study of Perioperative Ischemia Research Group: Long-term cardiac prognosis following non-cardiac surgery. JAMA 1992, 268:233–239. Howell SJ, Hemming AE, Allman KG, et al.: Predictors of postoperative myocardial ischaemia: the role of intercurrent arterial hypertension and other cardiovascular risk factors. Anaesthesia 1997, 52:107–111. Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993, 153:598–615. Sear JW, Foex P, Howell SJ: Effect of chronic intercurrent medication with beta-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia. Br J Anaesth 2000, 84:311–315. Pons-Llado G, Ballester M, Borras X, et al.: Myocardial cell damage in human hypertension. J Am Coll Cardiol 2000, 36:2198–2203. Reddy GC, Kusumanjali G, Sharada AHR, Rao P: Cardiac troponin-T and CK-MB (mass) levels in cardiac and noncardiac disease. Indian J Clin Biochem 2004, 19:91–94. Howell SJ, Sear JW, Foex P: Hypertension, hypertensive heart disease and perioperative cardiac risk. Br J Anaesth 2004, 92:570–583. Kheterpal K, Tremper KK, Englesbe MJ, et al.: Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007, 107:892–902. Howell SJ, Sear YM, Yeates D, et al.: Hypertension, admission blood pressure and perioperative cardiovascular risk. Anaesthesia 1996, 51:1000–1004. Howell SJ, Sear YM, Yeates D, et al.: Risk factors for cardiovascular death following elective surgery under general anaesthesia. Br J Anaesth 1998, 80:14–19. Aronson S, Boisvert D, Lapp W: Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg 2002, 94:1079–1084. Bond R, Narayan SK, Rothwell PL, Warlow CP: Clinical and radiologic risk factors for operative stroke and death in the European Carotid Surgery trial. Eur J Vasc Endovasc Surg 2002, 23:108–116. Felmeden DC, Lip GY, Beevers M, Beevers DG: The placebo effect and white coat effect in isolated systolic hypertension and systo-diastolic hypertension. Blood Press 2000, 9:335–339. Tamborini G, Maltagliata A, Trupiano L, et al.: Lowering of blood pressure and coronary blood flow in isolated systolic hypertension. Coron Artery Dis 2001, 12:259–265. Aronson S, Fontes ML, Miao Y, Mangano DT; Investigators of the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation: Risk index for perioperative renal dysfunction/failure. Critical dependence on pulse pressure hypertension. Circulation 2007, 115:733–742. Benjo A, Thompson RE, Fine D, et al.: Pulse pressure is an age-independent predictor of stroke development after cardiac surgery. Hypertension 2007, 50, 630–635. Muscholl MW, Hense H-W, Brockel U, et al.: Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. Br Med J 1998, 317:565–570. Nalbantgil I, Onder R, Nalbantgil S, et al.: The prevalence of silent myocardial ischaemia in patients with white-coat hypertension. J Hum Hypertens 1998, 12:337–341. Kroen C: Does elevated blood pressure at the time of surgery increase perioperative cardiac risk? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit. Cleve Clin J Med 2006, 73:S5–S6.